KEY FINDINGS
The global influenza vaccine market is estimated to record a CAGR of 6.43% over the forecast period of 2020-2028. A surge in the cases of influenza is a significant factor fueling the market growth. The other driving factors for the market are the government immunization programs to eradicate ailments from society, along with technological advancements.
MARKET INSIGHTS
Influenza is an acute respiratory illness caused by the influenza virus that affects the respiratory tract. Influenza viruses change continuously. Hence the vaccines have to be changed annually to match with the circulating influenza strains globally. The focus of various immunization programs is on increasing awareness among people towards vaccinations. For example, NAIIS AND CDC across the U.S. have undertaken some of the successful influenza vaccination initiatives. The recommendations made by the CDC are highly reliable and enhance the utilization of vaccines.
The high cost of vaccine development is one of the challenges faced by the market. The development of vaccines comprises of various phases, and the overall time period required from the development to the launch of the vaccine, may take 15-20 years. The overall development requires high monetary investments, which is estimated to be $200 million and $500 million per vaccine. The intensity of competition is high in the market as the market is dominated by a few established players. The quadrivalent influenza vaccine captured the highest market share in type segment in 2019, and is also estimated to be the fastest-growing influenza vaccine type.
REGIONAL INSIGHTS
The global influenza vaccine market is analyzed on the basis of the markets situated in North America, Europe, Asia Pacific, and the Rest of the world. The North American region dominates in terms of revenue, which is attributed to the rising incidences of influenza.
COMPETITIVE INSIGHTS
The market is dominated by well-established players such as Pfizer, Inc, Merck, Sanofi, Novartis AG, F. Hoffmann-La Roch Ltd, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Global Influenza Vaccine Market Forecast 2020-2028
Table of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates `
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis: Vaccine Market
3.2. Market Definition
3.3. Key Drivers
3.3.1. Government Immunization Programs To Eradicate Ailments From The Society
3.3.2. Rise In The Cases Of Influenza
3.3.3. Technology Advancement
3.4. Key Restraints
3.4.1. High Cost Of Development
3.4.2. Lengthy Process Of Development
4. Key Analytics
4.1. Key Investment Insights
4.2. Porter's Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
5. Market By Type
5.1. Quadrivalent Vaccine
5.2. Trivalent Vaccine
6. Market By Technology
6.1. Egg-Based Technology
6.2. Cell-Based Technology
7. Market By Age Group
7.1. Pediatric Age Group
7.2. Adult Age Group
8. Market By Delivery Mode
8.1. Injection
8.2. Nasal Spray
9. Geographical Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. United Kingdom
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Russia
9.2.6. Belgium
9.2.7. Poland
9.2.8. Rest Of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia & New Zealand
9.3.6. Thailand
9.3.7. Indonesia
9.3.8. Vietnam
9.3.9. Rest Of Asia Pacific
9.4. Rest Of World
9.4.1. Latin America
9.4.2. Middle East & Africa
10. Company Profiles
10.1. Merck
10.2. Novartis Ag
10.3. Pfizer, Inc
10.4. Sanofi
10.5. Biodiem
10.6. Emergent Biosolutions
10.7. F. Hoffmann-La Roche Ltd
10.8. Glaxosmithkline
10.9. Abbott
10.10. Csl Ltd
List of Tables
Table 1: Market Snapshot - Influenza Vaccine
Table 2: Global Influenza Vaccine Market, By Type, Historical Years, 2016-2019 (In $ Million)
Table 3: Global Influenza Vaccine Market, By Type, Forecast Years, 2020-2028 (In $ Million)
Table 4: Global Quadrivalent Vaccine Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 5: Global Quadrivalent Vaccine Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 6: Global Trivalent Vaccine Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 7: Global Trivalent Vaccine Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 8: Global Influenza Vaccine Market, By Technology, Historical Years, 2016-2019 (In $ Million)
Table 9: Global Influenza Vaccine Market, By Technology, Forecast Years, 2020-2028 (In $ Million)
Table 10: Global Egg-Based Technology Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 11: Global Egg-Based Technology Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 12: Global Cell-Based Technology Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 13: Global Cell-Based Technology Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 14: Global Influenza Vaccine Market, By Age Group, Historical Years, 2016-2019 (In $ Million)
Table 15: Global Influenza Vaccine Market, By Age Group, Forecast Years, 2020-2028 (In $ Million)
Table 16: Global Pediatric Age Group Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 17: Global Pediatric Age Group Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 18: Global Adult Age Group Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 19: Global Adult Age Group Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 20: Global Influenza Vaccine Market, By Delivery Mode, Historical Years, 2016-2019 (In $ Million)
Table 21: Global Influenza Vaccine Market, By Delivery Mode, Forecast Years, 2020-2028 (In $ Million)
Table 22: Global Injection Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 23: Global Injection Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 24: Global Nasal Spray Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 25: Global Nasal Spray Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 26: Global Influenza Vaccine Market, By Geography, Historical Years, 2016-2019 (In $ Million)
Table 27: Global Influenza Vaccine Market, By Geography, Forecast Years, 2020-2028 (In $ Million)
Table 28: North America Influenza Vaccine Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 29: North America Influenza Vaccine Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 30: Europe Influenza Vaccine Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 31: Europe Influenza Vaccine Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 32: Asia Pacific Influenza Vaccine Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 33: Asia Pacific Influenza Vaccine Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 34: Rest Of World Influenza Vaccine Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 35: Rest Of World Influenza Vaccine Market, By Region, Forecast Years, 2020-2028 (In $ Million)
List of Figures
Figure 1: Key Investment Insights
Figure 2: Porter's Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Global Influenza Vaccine Market, Growth Potential, By Type, In 2019
Figure 6: Global Influenza Vaccine Market, By Quadrivalent Vaccine, 2020-2028 (In $ Million)
Figure 7: Global Influenza Vaccine Market, By Trivalent Vaccine, 2020-2028 (In $ Million)
Figure 8: Global Influenza Vaccine Market, Growth Potential, By Technology, In 2019
Figure 9: Global Influenza Vaccine Market, By Egg-Based Technology, 2020-2028 (In $ Million)
Figure 10: Global Influenza Vaccine Market, By Cell-Based Technology, 2020-2028 (In $ Million)
Figure 11: Global Influenza Vaccine Market, Growth Potential, By Age Group, In 2019
Figure 12: Global Influenza Vaccine Market, By Pediatric Age Group, 2020-2028 (In $ Million)
Figure 13: Global Influenza Vaccine Market, By Adult Age Group, 2020-2028 (In $ Million)
Figure 14: Global Influenza Vaccine Market, Growth Potential, By Delivery Mode, In 2019
Figure 15: Global Influenza Vaccine Market, By Injection, 2020-2028 (In $ Million)
Figure 16: Global Influenza Vaccine Market, By Nasal Spray, 2020-2028 (In $ Million)
Figure 17: North America Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 18: United States Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 19: Canada Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 20: Europe Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 21: United Kingdom Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 22: Germany Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 23: France Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 24: Italy Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 25: Russia Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 26: Belgium Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 27: Poland Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 28: Rest Of Europe Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 29: Asia Pacific Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 30: China Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 31: Japan Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 32: India Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 33: South Korea Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 34: Australia & New Zealand Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 35: Thailand Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 36: Indonesia Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 37: Vietnam Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 38: Rest Of Asia Pacific Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 39: Rest Of World Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 40: Latin America Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 41: Middle East & Africa Influenza Vaccine Market, 2020-2028 (In $ Million)
Global Encephalitis Vaccination Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 102
According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 123
Market Overview of Global Avian Influenza Vaccines market:
According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period.
The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
Global Avian Influenza Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Encephalitis Vaccination market:
According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
Global Influenza Vaccine Market Research Report 2023
Published: 28-Dec-2023 Price: US 2900 Onwards Pages: 96
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- BCHT
- Jiangsu G......
Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Japanese Encephalitis Vaccine market:
According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 14-Dec-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Influenza Vaccine market:
According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses...
......
2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
Published: 11-Dec-2023 Price: US 2500 Onwards Pages: 107
This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Influenza Vaccine from......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
